Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK | BSE: 532296
Mid-range Performer
Download real time
1958.20
-13.50
(
-0.68
%)
53.52% Gain from 52W Low
563.3K
NSE+BSE Volume
NSE
29 Sep, 2025 3:57 PM (IST)
Watchlist
Portfolio
Alert
My Notes
BUY STOCK
Dividend
Glenmark Pharmaceuticals Ltd. has an upcoming dividend of ₹2.50 per share due on 03 Oct 2025
See details
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls
Keep track of all breaking news and updates on Glenmark Pharmaceuticals Ltd. from all sources in a single place.
All
News
Earnings Calls
Corporate Announcements
Research Reports
Load latest
Is Glenmark Pharmaceuticals Ltd. worth buying?
573 Votes:
Buy
79.41%
Sell
13.61%
Hold
6.98%
BUY
SELL
HOLD
RESEARCH REPORTS
Accumulate
SEE REPORTS >
09 Sep 2025
pdf
Glenmark Pharmaceuti..
by Geojit BNP Paribas
| Target:
2306
| Upside:
17.76%
Buy
SEE REPORTS >
02 Sep 2025
pdf
Glenmark Pharmaceuti..
by Deven Choksey
| Target:
2300
| Upside:
17.45%
All reports of GLENMARK